Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Boehringer Ingelheim
McKesson
Medtronic
Baxter

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Litigation for ESOMEPRAZOLE MAGNESIUM; NAPROXEN

See Plans and Pricing

« Back to Dashboard

US Court Litigation for ESOMEPRAZOLE MAGNESIUM; NAPROXEN

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
5,714,504   Start Trial   Start Trial 2012-12-07 15:1 Antitrust Litigation District Court, D. Massachusetts Both   Start Trial
5,714,504 Walgreen Co. v. Astrazeneca AB   Start Trial 2013-02-21 District Court, D. Massachusetts   Start Trial
5,714,504   Start Trial   Start Trial 2013-07-03 Court of Appeals for the Federal Circuit   Start Trial
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Patent Trial and Appeal Board Cases for ESOMEPRAZOLE MAGNESIUM; NAPROXEN

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
6,926,907 Coalition for Affordable Drugs VII LLC   Start Trial 2015-05-21 2015-05-21 POZEN Inc. Inter partes review   Start Trial 2015-12-08 John Plachetka   Start Trial
8,557,285 Dr. Reddy's Lab., Inc.   Start Trial 2015-02-24 2015-02-24 Pozen Inc. Inter partes review   Start Trial 2015-10-09 John Plachetka   Start Trial
8,852,636 Coalition for Affordable Drugs VII LLC   Start Trial 2015-08-07 2015-08-07 Pozen Inc. Inter partes review   Start Trial 2016-02-11 John PLACHETKA   Start Trial
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.